<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00242567</url>
  </required_header>
  <id_info>
    <org_study_id>CZOL446E2432</org_study_id>
    <nct_id>NCT00242567</nct_id>
  </id_info>
  <brief_title>Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer</brief_title>
  <official_title>A Phase III, Parallel Group, Randomized, Open-label, Multi-centre Clinical Trial of Zoledronic Acid in Males Receiving Androgen Deprivation Therapy for Advanced Prostate Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <brief_summary>
    <textblock>
      This study aims to determine whether early treatment with zoledronic acid, that is given
      during the early phase of advanced prostate cancer, will be more efficacious than delayed
      treatment
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2005</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skeletal-related Event-free Survival in Men With Bone Metastases From Prostate Cancer</measure>
    <time_frame>18 months</time_frame>
    <description>Skeletal-related event free survival is the time from randomization until the first detected Skeletal Related Event (SRE). Patients who were still SRE-free at 18 months were censored.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall Survival at 18 Months and 3 Years</measure>
    <time_frame>month 18, year 3</time_frame>
    <description>Overall survival (OS) time was measured from the start of study drug to the date of death due to any cause.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Occurrence of Skeletal Related Event or Death</measure>
    <time_frame>18 Months</time_frame>
    <description>Time from randomization to the first detected skeletal related event or death. This endpoint is the same as the primary endpoint with the modification that deaths are considered events.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skeletal-related Event(SRE)-Free Survival</measure>
    <time_frame>36 months</time_frame>
    <description>Time from randomization until the first detected SRE. Patients who were still SRE-free at 3 years were censored.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Occurrence of Skeletal Related Event or Death</measure>
    <time_frame>36 Months</time_frame>
    <description>Time from randomization to the first detected skeletal related event or death. This endpoint is the same as the primary endpoint with the modification that deaths are considered events.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">522</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Early Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing at Baseline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Delayed group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing no sooner than 12 months after their baseline visit, and not until they have had three rises in PSA level from Baseline, one of which must be a least 10 ng/mL greater than the baseline Serum Prostate-specific Antigen (PSA) level.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Zoledronic Acid</intervention_name>
    <description>Zoledronic acid was provided by Novartis in vials containing 4 mg/5 mL liquid concentrate. Prior to administration, the liquid concentrate from one vial was to be further diluted with 100 mL of calcium-free infusion solution (0.9 % weight by volume sodium chloride solution or 5 % weight by volume glucose solution). If refrigerated, the solution had to be allowed to reach room temperature before administration.
After addition of the liquid concentrate to the infusion media, the infusion solution was to be used as soon as practicable to reduce the risk of microbiological hazard. If storage of the solution was necessary, it had to be refrigerated at temperatures between 2-8 degrees C and was to be used within 24 hours.
The infusion solution containing 4 mg zoledronic acid was to be administered every 4 weeks as an i.v. infusion over no less than 15 minutes.</description>
    <arm_group_label>Early Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Androgen Deprivation Therapy (ADT)</intervention_name>
    <description>Androgen deprivation therapy (ADT) was to be administered according to institutional protocols, in accordance with relevant prescribing information. The type and duration of androgen deprivation was at the discretion of the treating specialist, and could include orchiectomy where this would normally have been performed. Androgen deprivation therapy was provided by the investigational center, or obtained by the patient from usual sources. Anti-androgen monotherapy and intermittent ADT were excluded in the first 12 months of the study.</description>
    <arm_group_label>Delayed group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  prostate cancer

          -  at least one bone metastasis

          -  receiving or about to receive androgen deprivation therapy (ADT)

        Exclusion Criteria:

          -  previous ADT failure

          -  previous or current treatment with another bone-protecting agent, chemotherapy or
             targeted therapy

          -  abnormal renal function

        Other protocol-defined inclusion/exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Novartis Pharmaceuticals</last_name>
    <role>Study Director</role>
    <affiliation>Novartis Pharmaceuticals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Adelaide</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Brisbane</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Melbourne</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Port Macquarie</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sydney</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Porto Alegre</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Santo Andre</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Chongqing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kyunggi-do</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Kuwait</city>
        <country>Kuwait</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Christchurch</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Hamilton</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Tauranga</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Wellington</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Taoyuan</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novartis Investigative Site</name>
      <address>
        <city>Songkhla</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Brazil</country>
    <country>China</country>
    <country>Korea, Republic of</country>
    <country>Kuwait</country>
    <country>Lebanon</country>
    <country>New Zealand</country>
    <country>Saudi Arabia</country>
    <country>Taiwan</country>
    <country>Thailand</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 19, 2005</study_first_submitted>
  <study_first_submitted_qc>October 19, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2005</study_first_posted>
  <results_first_submitted>January 29, 2013</results_first_submitted>
  <results_first_submitted_qc>January 29, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 6, 2013</results_first_posted>
  <last_update_submitted>April 14, 2014</last_update_submitted>
  <last_update_submitted_qc>April 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>zoledronic acid</keyword>
  <keyword>bone metastases</keyword>
  <keyword>prostate cancer</keyword>
  <keyword>hormone-sensitive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Androgens</mesh_term>
    <mesh_term>Zoledronic acid</mesh_term>
    <mesh_term>Diphosphonates</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>552 patients enrolled, but 30 patients were excluded due to GCP issues in one country.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Early Group</title>
          <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing at Baseline.</description>
        </group>
        <group group_id="P2">
          <title>Delayed Group</title>
          <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing no sooner than 12 months after their baseline visit, and not until they have had three rises in PSA level from Baseline, one of which must be a least 10 ng/mL greater than the baseline PSA level.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="259"/>
                <participants group_id="P2" count="263"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Received at Least 1 Dose of Study Drug</title>
              <participants_list>
                <participants group_id="P1" count="259"/>
                <participants group_id="P2" count="72"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Never Received Study Drug</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="191"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="93"/>
                <participants group_id="P2" count="123"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="166"/>
                <participants group_id="P2" count="140"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="70"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Disease Progression</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Symptomatic deterioration</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Use of an inhibitor of bone resorption</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Early Group</title>
          <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing at Baseline.</description>
        </group>
        <group group_id="B2">
          <title>Delayed Group</title>
          <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing no sooner than 12 months after their baseline visit, and not until they have had three rises in PSA level from Baseline, one of which must be a least 10 ng/mL greater than the baseline PSA level.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="259"/>
            <count group_id="B2" value="263"/>
            <count group_id="B3" value="522"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.4" spread="8.46"/>
                    <measurement group_id="B2" value="70.2" spread="8.26"/>
                    <measurement group_id="B3" value="69.8" spread="8.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="259"/>
                    <measurement group_id="B2" value="263"/>
                    <measurement group_id="B3" value="522"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Skeletal-related Event-free Survival in Men With Bone Metastases From Prostate Cancer</title>
        <description>Skeletal-related event free survival is the time from randomization until the first detected Skeletal Related Event (SRE). Patients who were still SRE-free at 18 months were censored.</description>
        <time_frame>18 months</time_frame>
        <population>The ITT Population will consist of all patients randomized to treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Early Group</title>
            <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing at Baseline.</description>
          </group>
          <group group_id="O2">
            <title>Delayed Group</title>
            <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing no sooner than 12 months after their baseline visit, and not until they have had three rises in PSA level from Baseline, one of which must be a least 10 ng/mL greater than the baseline PSA level.</description>
          </group>
        </group_list>
        <measure>
          <title>Skeletal-related Event-free Survival in Men With Bone Metastases From Prostate Cancer</title>
          <description>Skeletal-related event free survival is the time from randomization until the first detected Skeletal Related Event (SRE). Patients who were still SRE-free at 18 months were censored.</description>
          <population>The ITT Population will consist of all patients randomized to treatment.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="259"/>
                <count group_id="O2" value="263"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients with event (s)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                    <measurement group_id="O2" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients without event (censored)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="201"/>
                    <measurement group_id="O2" value="214"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Survival at 18 Months and 3 Years</title>
        <description>Overall survival (OS) time was measured from the start of study drug to the date of death due to any cause.</description>
        <time_frame>month 18, year 3</time_frame>
        <population>The ITT Population will consist of all patients randomized to treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Early Group</title>
            <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing at Baseline.</description>
          </group>
          <group group_id="O2">
            <title>Delayed Group</title>
            <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing no sooner than 12 months after their baseline visit, and not until they have had three rises in PSA level from Baseline, one of which must be a least 10 ng/mL greater than the baseline PSA level.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Survival at 18 Months and 3 Years</title>
          <description>Overall survival (OS) time was measured from the start of study drug to the date of death due to any cause.</description>
          <population>The ITT Population will consist of all patients randomized to treatment.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="259"/>
                <count group_id="O2" value="263"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Patients with event (s) - 18 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients without event - 18 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="228"/>
                    <measurement group_id="O2" value="242"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with event (s) - 36 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients without event - 36 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="210"/>
                    <measurement group_id="O2" value="219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Occurrence of Skeletal Related Event or Death</title>
        <description>Time from randomization to the first detected skeletal related event or death. This endpoint is the same as the primary endpoint with the modification that deaths are considered events.</description>
        <time_frame>18 Months</time_frame>
        <population>The ITT Population consisted of all patients randomized to treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Early Group</title>
            <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing at Baseline.</description>
          </group>
          <group group_id="O2">
            <title>Delayed Group</title>
            <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing no sooner than 12 months after their baseline visit, and not until they have had three rises in PSA level from Baseline, one of which must be a least 10 ng/mL greater than the baseline PSA level.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Occurrence of Skeletal Related Event or Death</title>
          <description>Time from randomization to the first detected skeletal related event or death. This endpoint is the same as the primary endpoint with the modification that deaths are considered events.</description>
          <population>The ITT Population consisted of all patients randomized to treatment.</population>
          <units>Days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="259"/>
                <count group_id="O2" value="263"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Median time to event was not calculable due to less than 50% of patients had an event of SRE or Death at 18 months</measurement>
                    <measurement group_id="O2" value="NA">Median time to event was not calculable due to less than 50% of patients had an event of SRE or Death at 18 months</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Skeletal-related Event(SRE)-Free Survival</title>
        <description>Time from randomization until the first detected SRE. Patients who were still SRE-free at 3 years were censored.</description>
        <time_frame>36 months</time_frame>
        <population>The ITT Population consisted of all patients randomized to treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Early Group</title>
            <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing at Baseline.</description>
          </group>
          <group group_id="O2">
            <title>Delayed Group</title>
            <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing no sooner than 12 months after their baseline visit, and not until they have had three rises in PSA level from Baseline, one of which must be a least 10 ng/mL greater than the baseline PSA level.</description>
          </group>
        </group_list>
        <measure>
          <title>Skeletal-related Event(SRE)-Free Survival</title>
          <description>Time from randomization until the first detected SRE. Patients who were still SRE-free at 3 years were censored.</description>
          <population>The ITT Population consisted of all patients randomized to treatment.</population>
          <units>Days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="259"/>
                <count group_id="O2" value="263"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">Median time to event was not calculable due to less than 50% of patients had an event of SRE at 36 months</measurement>
                    <measurement group_id="O2" value="NA">Median time to event was not calculable due to less than 50% of patients had an event of SRE at 36 months</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Occurrence of Skeletal Related Event or Death</title>
        <description>Time from randomization to the first detected skeletal related event or death. This endpoint is the same as the primary endpoint with the modification that deaths are considered events.</description>
        <time_frame>36 Months</time_frame>
        <population>The ITT Population consisted of all patients randomized to treatment.</population>
        <group_list>
          <group group_id="O1">
            <title>Early Group</title>
            <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing at Baseline.</description>
          </group>
          <group group_id="O2">
            <title>Delayed Group</title>
            <description>Zoledronic acid 4 mg i.v. infusion every 4 weeks, commencing no sooner than 12 months after their baseline visit, and not until they have had three rises in PSA level from Baseline, one of which must be a least 10 ng/mL greater than the baseline PSA level.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Occurrence of Skeletal Related Event or Death</title>
          <description>Time from randomization to the first detected skeletal related event or death. This endpoint is the same as the primary endpoint with the modification that deaths are considered events.</description>
          <population>The ITT Population consisted of all patients randomized to treatment.</population>
          <units>Days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="259"/>
                <count group_id="O2" value="263"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="945">Median time to event was not calculable due to less than 50% of patients had an event of SRE or Death at 36 months</measurement>
                    <measurement group_id="O2" value="NA">Median time to event was not calculable due to less than 50% of patients had an event of SRE or Death at 36 months</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Early Group</title>
          <description>Early Group</description>
        </group>
        <group group_id="E2">
          <title>Delayed Group (Overall)</title>
          <description>Delayed Group (Overall)</description>
        </group>
        <group group_id="E3">
          <title>Delayed Group (No Zometa)</title>
          <description>Delayed Group (No Zometa)</description>
        </group>
        <group group_id="E4">
          <title>Delayed Group (Zometa)</title>
          <description>Delayed Group (Zometa)</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="121" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="104" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="67" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="37" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BONE MARROW FAILURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>FEBRILE BONE MARROW APLASIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>LEUKOCYTOSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>LEUKOPENIA</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>LYMPHADENOPATHY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PANCYTOPENIA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PROTEIN DEFICIENCY ANAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>THROMBOCYTOPENIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE MYOCARDIAL INFARCTION</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ANGINA PECTORIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ANGINA UNSTABLE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ATRIAL FIBRILLATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ATRIAL FLUTTER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ATRIOVENTRICULAR BLOCK FIRST DEGREE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BUNDLE BRANCH BLOCK RIGHT</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CARDIAC ARREST</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CARDIAC DISCOMFORT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE ACUTE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE CHRONIC</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE CONGESTIVE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CARDIO-RESPIRATORY ARREST</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CARDIOGENIC SHOCK</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CARDIOTOXICITY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPERTENSIVE HEART DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>LEFT VENTRICULAR HYPERTROPHY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MYOCARDIAL INFARCTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PALPITATIONS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>SINUS TACHYCARDIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>PHIMOSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>TINNITUS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>GOITRE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>CATARACT</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CATARACT NUCLEAR</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DIPLOPIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>EYE PAIN</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>OPHTHALMOPLEGIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ORBITAL OEDEMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>RETINAL DETACHMENT</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>VISION BLURRED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>VISUAL IMPAIRMENT</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL DISTENSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ANAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CAECITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CONSTIPATION</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DENTAL CARIES</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DUODENAL ULCER HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DUODENAL ULCER PERFORATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DYSPHAGIA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>GASTRITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>GASTRITIS EROSIVE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL INFLAMMATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>INGUINAL HERNIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>INTESTINAL OBSTRUCTION</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>INTESTINAL PERFORATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MELAENA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MOUTH ULCERATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL VARICES HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PANCREATITIS ACUTE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PEPTIC ULCER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PROCTITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>REFLUX OESOPHAGITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>UPPER GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>ABASIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ASTHENIA</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CATHETER SITE PAIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CHEST DISCOMFORT</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CHEST PAIN</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CHILLS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CONCOMITANT DISEASE PROGRESSION</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DEATH</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DISEASE PROGRESSION</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DRUG INEFFECTIVE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>FACE OEDEMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>FATIGUE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>FEELING COLD</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>GAIT DISTURBANCE</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>GENERAL PHYSICAL HEALTH DETERIORATION</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>GENERALISED OEDEMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MALAISE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MUCOSAL INFLAMMATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MULTI-ORGAN DISORDER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MULTI-ORGAN FAILURE</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>NON-CARDIAC CHEST PAIN</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>OEDEMA PERIPHERAL</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PAIN</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PELVIC MASS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PERFORMANCE STATUS DECREASED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PYREXIA</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>SUPRAPUBIC PAIN</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ULCER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>BILIARY DILATATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BUDD-CHIARI SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CHOLANGITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CHOLANGITIS ACUTE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CHOLELITHIASIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HEPATIC INFARCTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HEPATIC LESION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HEPATITIS TOXIC</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HEPATOMEGALY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HEPATORENAL FAILURE</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HEPATORENAL SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>JAUNDICE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PORTAL HYPERTENSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>ABSCESS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BRONCHITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BRONCHOPNEUMONIA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CARBUNCLE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CELLULITIS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DIARRHOEA INFECTIOUS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DIVERTICULITIS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ECZEMA INFECTED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ENTEROCOLITIS INFECTIOUS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ESCHERICHIA URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS VIRAL</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>INFECTED SKIN ULCER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>INFLUENZA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>LOBAR PNEUMONIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>LOWER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>LUNG INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>NECROTISING FASCIITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>NOSOCOMIAL INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ORAL CANDIDIASIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>OROPHARYNGITIS FUNGAL</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>OSTEOMYELITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>OSTEOMYELITIS CHRONIC</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PNEUMONIA</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PNEUMONIA PRIMARY ATYPICAL</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE WOUND INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>RECTAL ABSCESS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>SEPSIS</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>SEPTIC SHOCK</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>SINUSITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>SKIN INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>STAPHYLOCOCCAL SKIN INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>UROSEPSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>VIRAL INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>WOUND INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>ANIMAL BITE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>FALL</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>FEMORAL NECK FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>FEMUR FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS RADIATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HEAD INJURY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HUMERUS FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PENIS INJURY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE THORACIC PROCEDURE COMPLICATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>SKELETAL INJURY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>SPINAL COMPRESSION FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>SUBDURAL HAEMATOMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>WOUND</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>WOUND DEHISCENCE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>BLOOD ALBUMIN DECREASED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BLOOD BILIRUBIN INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BLOOD CREATINE INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BLOOD CREATINE PHOSPHOKINASE INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BLOOD CREATININE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BLOOD CREATININE INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BLOOD LACTATE DEHYDROGENASE INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BLOOD MAGNESIUM INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BLOOD PHOSPHORUS INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BLOOD POTASSIUM DECREASED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BLOOD POTASSIUM INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BLOOD TESTOSTERONE INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BONE SCAN ABNORMAL</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ELECTROCARDIOGRAM ABNORMAL</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ELECTROCARDIOGRAM ST-T CHANGE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HAEMOGLOBIN DECREASED</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HEPATIC ENZYME INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HEPATITIS C POSITIVE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>INTERNATIONAL NORMALISED RATIO INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>LYMPHOCYTE COUNT DECREASED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PLATELET COUNT DECREASED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PROSTATIC SPECIFIC ANTIGEN INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PROTEIN TOTAL DECREASED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>TROPONIN INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>URINE OUTPUT DECREASED</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>WEIGHT DECREASED</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>CACHEXIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DECREASED APPETITE</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DEHYDRATION</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DIABETES MELLITUS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DIABETES MELLITUS INADEQUATE CONTROL</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>FLUID INTAKE REDUCED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>GOUT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPERKALAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPOALBUMINAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPOCALCAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPOGLYCAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPOKALAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPONATRAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPOPHAGIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPOPHOSPHATAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MALNUTRITION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MARASMUS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>METABOLIC ACIDOSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>TYPE 1 DIABETES MELLITUS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>VITAMIN D DEFICIENCY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ARTHRALGIA</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BACK PAIN</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BONE PAIN</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>INTERVERTEBRAL DISC DEGENERATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MOBILITY DECREASED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MUSCULAR WEAKNESS</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL CHEST PAIN</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MYALGIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>OSTEOARTHRITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>OSTEONECROSIS</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PAIN IN EXTREMITY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PAIN IN JAW</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PATHOLOGICAL FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>B-CELL LYMPHOMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BASAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BILE DUCT CANCER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BLADDER TRANSITIONAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BONE MARROW TUMOUR CELL INFILTRATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BONE NEOPLASM</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BRAIN NEOPLASM</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BRONCHIAL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HEAD AND NECK CANCER</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>LIP AND/OR ORAL CAVITY CANCER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>LUNG NEOPLASM MALIGNANT</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MALIGNANT MELANOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MALIGNANT NEOPLASM PROGRESSION</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>METASTASES TO BONE</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>METASTASES TO BONE MARROW</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>METASTASES TO CENTRAL NERVOUS SYSTEM</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>METASTASES TO LIVER</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>METASTASES TO LUNG</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>METASTASES TO LYMPH NODES</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>METASTASES TO NERVOUS SYSTEM</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>METASTASES TO SPINE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>METASTASIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>METASTATIC NEOPLASM</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>METASTATIC PAIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>NEOPLASM PROGRESSION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>NEUROENDOCRINE TUMOUR</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>NON-SMALL CELL LUNG CANCER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ORAL NEOPLASM</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PANCOAST'S TUMOUR</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PROSTATE CANCER</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PROSTATE CANCER METASTATIC</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>RECTAL CANCER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>RENAL CANCER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>SQUAMOUS CELL CARCINOMA OF THE CERVIX</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>TRANSITIONAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>ALTERED STATE OF CONSCIOUSNESS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>APHASIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BASAL GANGLIA HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CARPAL TUNNEL SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CAUDA EQUINA SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CEREBELLAR INFARCTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CEREBRAL ARTERY OCCLUSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CEREBRAL ARTERY STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CEREBRAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CEREBRAL INFARCTION</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CEREBRAL ISCHAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CEREBROVASCULAR ACCIDENT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>COMA HEPATIC</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>COMA URAEMIC</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CONVULSION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DEMENTIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DIABETIC MONONEUROPATHY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DYSSTASIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>FACIAL PALSY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>GUILLAIN-BARRE SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HORNER'S SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPOAESTHESIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPOGLYCAEMIC COMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>INTRACRANIAL HAEMATOMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>LACUNAR INFARCTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>LOSS OF CONSCIOUSNESS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PARAESTHESIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PARAPARESIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PARAPLEGIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>SPINAL CORD COMPRESSION</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>SPINAL MENINGEAL CYST</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>SYNCOPE</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>TRANSIENT ISCHAEMIC ATTACK</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>ANXIETY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CONFUSIONAL STATE</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DEPRESSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DISORIENTATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MENTAL STATUS CHANGES</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>ANURIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>AZOTAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BLADDER NECK OBSTRUCTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BLADDER OBSTRUCTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CALCULUS BLADDER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CALCULUS URETERIC</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DYSURIA</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HAEMATURIA</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYDRONEPHROSIS</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>NOCTURIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>POLYURIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PYELOCALIECTASIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>RENAL FAILURE</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>RENAL FAILURE ACUTE</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>RENAL IMPAIRMENT</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>RENAL INFARCT</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>URETERAL DISORDER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>URETERIC OBSTRUCTION</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>URETHRAL DILATATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>URETHRAL STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>URINARY BLADDER HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>URINARY INCONTINENCE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>URINARY RETENTION</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>URINARY TRACT DISORDER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>URINARY TRACT OBSTRUCTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>BENIGN PROSTATIC HYPERPLASIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BREAST PAIN</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PENILE PAIN</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PROSTATOMEGALY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>ASTHMA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CHRONIC OBSTRUCTIVE PULMONARY DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>COUGH</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DYSPNOEA</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DYSPNOEA EXERTIONAL</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>EMPHYSEMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HAEMOPTYSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>INTERSTITIAL LUNG DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>LUNG DISORDER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PLEURAL EFFUSION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PLEURITIC PAIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PNEUMOTHORAX</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PRODUCTIVE COUGH</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PULMONARY EMBOLISM</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PULMONARY INFARCTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PULMONARY OEDEMA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>RESPIRATORY ARREST</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>RESPIRATORY FAILURE</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>STRIDOR</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ERYTHEMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HAEMORRHAGE SUBCUTANEOUS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>TRANSURETHRAL PROSTATECTOMY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>AORTIC ANEURYSM</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ARTERIAL STENOSIS LIMB</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DEEP VEIN THROMBOSIS</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>EXTRINSIC VASCULAR COMPRESSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPERTENSIVE CRISIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPOTENSION</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>SHOCK</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="220" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="197" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="135" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="62" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="18" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>LYMPHADENOPATHY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>NEUTROPENIA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>THROMBOCYTOPENIA</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN UPPER</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>CONSTIPATION</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="53" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="33" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="20" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DYSPEPSIA</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="14" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>ASTHENIA</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>FATIGUE</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>INFLUENZA LIKE ILLNESS</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>OEDEMA PERIPHERAL</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PAIN</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PYREXIA</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>LOWER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>NASOPHARYNGITIS</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>UPPER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>FALL</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>SKIN LACERATION</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>BLOOD CREATININE INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="56" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PROSTATIC SPECIFIC ANTIGEN INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="60" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="61" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="26" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="35" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>WEIGHT DECREASED</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>WEIGHT INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>DECREASED APPETITE</sub_title>
                <counts group_id="E1" subjects_affected="35" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPOCALCAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPOPHOSPHATAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ARTHRALGIA</sub_title>
                <counts group_id="E1" subjects_affected="53" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="46" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="28" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="18" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BACK PAIN</sub_title>
                <counts group_id="E1" subjects_affected="61" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="54" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="28" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="26" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>BONE PAIN</sub_title>
                <counts group_id="E1" subjects_affected="34" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MUSCLE SPASMS</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MUSCULAR WEAKNESS</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL CHEST PAIN</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL DISCOMFORT</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL STIFFNESS</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>MYALGIA</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>NECK PAIN</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PAIN IN EXTREMITY</sub_title>
                <counts group_id="E1" subjects_affected="36" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="42" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="24" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>METASTATIC PAIN</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PROSTATE CANCER</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>DIZZINESS</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPOAESTHESIA</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>PARAESTHESIA</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>DEPRESSED MOOD</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>INSOMNIA</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>DYSURIA</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HAEMATURIA</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYDRONEPHROSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>NOCTURIA</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>POLLAKIURIA</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>URINARY RETENTION</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>PELVIC PAIN</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>COUGH</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>DYSPNOEA</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>HOT FLUSH</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="72"/>
              </event>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="259"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="263"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="72"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.
The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Novartis Pharmaceuticals</organization>
      <phone>862-778-8300</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

